Demron receives patent approval

29/01/2009

President and CEO at Radiation Shield Technologies (RST), Ronald DeMeo, has announced that the company has been granted US nanotechnology patent (No. 7,476,889), titled “Radiation Detectable and Protective Articles,” by the US Patent & Trademark Office.

The patent describes and protects the use of nanopolymeric compounds that enable the latest version of Demron, Demron-W, to provide enhanced chemical, biological, radiation and flame protection.

Demron consists of an advanced radiopaque nanopolymeric compound fused between layers of fabric and manufactured into lightweight nuclear-radiation blocking garments including full-body suits, vests, blankets and medical X-ray vests and aprons.

According to the company, its nanotechnology surpasses current NBC suits, which provide limited radioactive protection.

“As the manufacturer and marketer of advanced nuclear suits and personal-protection technologies that are in high demand worldwide, Radiation Shield Technologies developed an intellectual property strategy that gives us freedom to meet our customers’ radiation protection needs while safeguarding our company’s commercial advantages,” said Dr DeMeo, the surgeon who developed Demron.

Demron is a lead-free, toxin-free and PVC-free material that allows heat dissipation and resists chemical penetration and cracks. Its nuclear protection fabrics feel cool and, unlike some nuclear suits, they are lightweight, flexible and foldable.